slides · global inventory
Development
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 11,188
Current window 8,761-8,790
Pages 373
Rows per page 30
Beat
8,761-8,790 of 11,188
04
The slide uses a two-column layout to separate financial metrics from operational/strategic highlights.Allego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · Rising SuccessLoop · Elimination1 hit
05
The slide uses a three-column structure to define the business model, supported by data tables for charging ports and a footer highlighting energy sourcing benefits.Allego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · Rising SuccessLoop · Elimination1 hit
06
The slide uses a combination of a feature-set row and two columns of bulleted lists to explain the value proposition of the energy platform.Allego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · Rising SuccessLoop · Elimination1 hit
07
The slide uses a waterfall-like progression to show the growth of charging ports from operational to pipeline.Allego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · Rising SuccessLoop · Elimination1 hit
08
Allego | Results Presentation Deck | 16 slidesAllego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · Rising SuccessLoop · Elimination1 hit
09
Allego | Results Presentation Deck | 16 slidesAllego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · Rising SuccessLoop · Elimination1 hit
10
The slide uses bar charts to show year-over-year growth percentages for charging infrastructure.Allego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · Rising SuccessLoop · Elimination1 hit
07
Uses a geographic map and a nested circle diagram to illustrate the treatment gap.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
08
The slide uses a process-oriented flow diagram to explain the mechanism of action for a combination therapy.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
05
The slide uses a process diagram to contrast current clinical workflows with the proposed solution, followed by a bar chart illustrating the exponential mortality risk over time.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
BICR = Blinded Independent Central Review; RANO = Response Assessment in Neuro-Oncology; HGG = High-Grade Glioma; LGG = Low-Grade Glioma; SAEs = Serious Adverse Events.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
08
The slide details specific inclusion/exclusion criteria, including age, mutation status, prior therapy, and washout periods.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
09
The slide highlights clinical trial results with specific response and disease control rates for two different RANO criteria.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
10
The chart is a waterfall plot (often called a swimmer plot or spider plot in oncology, though technically a waterfall).Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
11
The chart is a waterfall plot showing Best % Change in SPD from Baseline. The legend indicates PS scores (060-100).Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
12
The chart is a classic 'spider plot' used in oncology clinical trials to visualize individual patient tumor burden changes over time.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
13
Data presented in two tables comparing healthy adult dose escalation vs glioma patient safety profiles.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
14
The slide highlights the correlation between RANO response criteria and improved clinical outcomes in H3 K27M-mutant DMG patients.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
15
The table uses a color-coded heatmap to highlight favorable (green) vs unfavorable (pink) characteristics of clinical trial data.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
15
Dare Bioscience | Investor Presentation Deck | 27 slidesDare Bioscience | Investor Presentation Deck | 27 slides · Daré Bioscience
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
15
The slide highlights the poor efficacy of current SOC and suggests binimetinib as a superior alternative.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
16
Waterfall plot uses standard clinical trial terminology (PD, SD, PR). Comparison table highlights the study drug's performance against Dacarbazine and Binimetinib.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
17
The slide uses a before-and-after visual comparison to demonstrate clinical efficacy.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
18
Swimmer plot visualization of clinical trial data (Trial LXH254X2102).Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
19
The slide highlights consistent clinical activity across two study phases, culminating in a combined ORR of 33.3%.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
20
Swimmer plot visualization of clinical trial data.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
05
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
09
The chart uses a grouped bar format to show revenue (dark) and EBITDA (light) over time, with specific annotations for pandemic impact and recent performance metrics.Grove | Investor Presentation Deck | 41 slides · Grove Collaborative
Pitch deck Investor relations Beat · Rising Success1 hit
10
Includes a valuation table and key performance indicators.Grove | Investor Presentation Deck | 41 slides · Grove Collaborative
Pitch deck Investor relations Beat · Rising Success1 hit
11
The slide uses a celebrity endorsement (Drew Barrymore) to establish brand authority and market potential.Grove | Investor Presentation Deck | 41 slides · Grove Collaborative
Pitch deck Investor relations Beat · Rising Success1 hit